Skip to main content

Table 3 Change in the impact of French Alzheimer disease research between the periods 2004–2008 and 2009–2013, as assessed by research output and representation in the top 1 % globally cited articles compared with French scientific output in stroke, Parkinson disease, HIV, and diabetes

From: The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact

 

Research output (% France’s share of output)

Output relative increase (fold change)

France’s share of top 1 % globally cited articles

Top 1 % relative increase (fold change)

 

2004–2008

2009–2013

2004–2008

2009–2013

Alzheimer disease

1, 082 (0.4 %)

1, 836 (0.6 %)

3.9

18 (0.7 %)

44 (1.1 %)

2.3

Diabetes

2, 890 (1.1 %)

3, 725 (1.2 %)

1.6

75 (3.0 %)

130 (3.2 %)

1.2

HIV

3, 092 (1.1 %)

3, 297 (1.0 %)

0.4

43 (1.7 %)

58 (1.4 %)

0.6

Parkinson disease

997 (0.4 %)

1, 281 (0.4 %)

1.6

17 (0.7 %)

21 (0.5 %)

0.4

Stroke

1, 495 (0.5 %)

2, 264 (0.7 %)

2.9

46 (1.8 %)

98 (2.0 %)

1.8

Overall

270, 314

318, 946

1

2, 496

4, 041

1